Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Dec;24(6):829–834. doi: 10.1128/aac.24.6.829

Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis.

J R Graybill, S R Kaster, D J Drutz
PMCID: PMC185391  PMID: 6318660

Abstract

Two new antifungal triazoles, BAY n7133 and ICI 153,066, were compared with ketoconazole in treatment of mice challenged intraperitoneally with Cryptococcus neoformans. At high challenge doses, thymus-containing normal mice had prolonged survival after treatment with BAY n7133. Athymic mice, which have severely deficient cell-mediated immunity, were not protected. At low challenge doses, athymic mice also had prolonged survival. Although BAY n7133 was protective, it was less effective than either ketoconazole or ICI 153,066. BAY n7133 was also less effective in mice challenged intracerebrally than in those challenged intraperitoneally. Both ketoconazole and ICI 153,066 prolonged survival and lowered cryptococcal spleen counts to a greater extent than did BAY n7133.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craven P. C., Graybill J. R., Jorgensen J. H. Ketoconazole therapy of murine cryptococcal meningitis. Am Rev Respir Dis. 1982 Jun;125(6):696–700. doi: 10.1164/arrd.1982.125.6.696. [DOI] [PubMed] [Google Scholar]
  2. Dismukes W. E., Stamm A. M., Graybill J. R., Craven P. C., Stevens D. A., Stiller R. L., Sarosi G. A., Medoff G., Gregg C. R., Gallis H. A. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med. 1983 Jan;98(1):13–20. doi: 10.7326/0003-4819-98-1-13. [DOI] [PubMed] [Google Scholar]
  3. Graybill J. R., Craven P. C., Mitchell L. F., Drutz D. J. Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis. Antimicrob Agents Chemother. 1978 Nov;14(5):659–667. doi: 10.1128/aac.14.5.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Graybill J. R., Williams D. M., Van Cutsem E., Drutz D. J. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):551–558. doi: 10.1093/clinids/2.4.551. [DOI] [PubMed] [Google Scholar]
  5. Jorgensen J. H., Alexander G. A., Graybill J. R., Drutz D. J. Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob Agents Chemother. 1981 Jul;20(1):59–62. doi: 10.1128/aac.20.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES